Global Angiotensin Receptor Blockers (ARBs) Market Research Report 2021

Global Angiotensin Receptor Blockers (ARBs) Market Research Report 2021

Table of Contents
1 Angiotensin Receptor Blockers (ARBs) Market Overview
1.1 Product Overview and Scope of Angiotensin Receptor Blockers (ARBs)
1.2 Angiotensin Receptor Blockers (ARBs) Segment by Type
1.2.1 Global Angiotensin Receptor Blockers (ARBs) Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Valsartan
1.2.3 Telmisartan
1.2.4 Losartan
1.2.5 Irbesartan
1.2.6 Azilsartan
1.2.7 Olmesartan
1.3 Angiotensin Receptor Blockers (ARBs) Segment by Application
1.3.1 Angiotensin Receptor Blockers (ARBs) Sales Comparison by Application: (2021-2027)
1.3.2 Hypertension
1.3.3 Cardiovascular Diseases
1.3.4 Kidney Diseases
1.3.5 Other
1.4 Global Angiotensin Receptor Blockers (ARBs) Market Size Estimates and Forecasts
1.4.1 Global Angiotensin Receptor Blockers (ARBs) Revenue 2016-2027
1.4.2 Global Angiotensin Receptor Blockers (ARBs) Sales 2016-2027
1.4.3 Angiotensin Receptor Blockers (ARBs) Market Size by Region: 2016 Versus 2021 Versus 2027
2 Angiotensin Receptor Blockers (ARBs) Market Competition by Manufacturers
2.1 Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Angiotensin Receptor Blockers (ARBs) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Angiotensin Receptor Blockers (ARBs) Manufacturing Sites, Area Served, Product Type
2.5 Angiotensin Receptor Blockers (ARBs) Market Competitive Situation and Trends
2.5.1 Angiotensin Receptor Blockers (ARBs) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Angiotensin Receptor Blockers (ARBs) Players Market Share by Revenue
2.5.3 Global Angiotensin Receptor Blockers (ARBs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Angiotensin Receptor Blockers (ARBs) Retrospective Market Scenario by Region
3.1 Global Angiotensin Receptor Blockers (ARBs) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Angiotensin Receptor Blockers (ARBs) Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Country
3.3.1 North America Angiotensin Receptor Blockers (ARBs) Sales by Country
3.3.2 North America Angiotensin Receptor Blockers (ARBs) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Country
3.4.1 Europe Angiotensin Receptor Blockers (ARBs) Sales by Country
3.4.2 Europe Angiotensin Receptor Blockers (ARBs) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Region
3.5.1 Asia Pacific Angiotensin Receptor Blockers (ARBs) Sales by Region
3.5.2 Asia Pacific Angiotensin Receptor Blockers (ARBs) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Country
3.6.1 Latin America Angiotensin Receptor Blockers (ARBs) Sales by Country
3.6.2 Latin America Angiotensin Receptor Blockers (ARBs) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Angiotensin Receptor Blockers (ARBs) Market Facts & Figures by Country
3.7.1 Middle East and Africa Angiotensin Receptor Blockers (ARBs) Sales by Country
3.7.2 Middle East and Africa Angiotensin Receptor Blockers (ARBs) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Angiotensin Receptor Blockers (ARBs) Historic Market Analysis by Type
4.1 Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type (2016-2021)
4.2 Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Type (2016-2021)
4.3 Global Angiotensin Receptor Blockers (ARBs) Price by Type (2016-2021)
5 Global Angiotensin Receptor Blockers (ARBs) Historic Market Analysis by Application
5.1 Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2016-2021)
5.2 Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Application (2016-2021)
5.3 Global Angiotensin Receptor Blockers (ARBs) Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Pfizer Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Novartis Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merck Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Astra Zeneca
6.4.1 Astra Zeneca Corporation Information
6.4.2 Astra Zeneca Description and Business Overview
6.4.3 Astra Zeneca Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Astra Zeneca Product Portfolio
6.4.5 Astra Zeneca Recent Developments/Updates
6.5 Jhonson and Johnson
6.5.1 Jhonson and Johnson Corporation Information
6.5.2 Jhonson and Johnson Description and Business Overview
6.5.3 Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Jhonson and Johnson Product Portfolio
6.5.5 Jhonson and Johnson Recent Developments/Updates
6.6 Eli Lilly
6.6.1 Eli Lilly Corporation Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Eli Lilly Product Portfolio
6.6.5 Eli Lilly Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sanofi Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Bristol-Myers Squibb
6.8.1 Bristol-Myers Squibb Corporation Information
6.8.2 Bristol-Myers Squibb Description and Business Overview
6.8.3 Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Bristol-Myers Squibb Product Portfolio
6.8.5 Bristol-Myers Squibb Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Corporation Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Bayer Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 GSK
6.10.1 GSK Corporation Information
6.10.2 GSK Description and Business Overview
6.10.3 GSK Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2016-2021)
6.10.4 GSK Product Portfolio
6.10.5 GSK Recent Developments/Updates
6.11 Teva Pharmaceutical
6.11.1 Teva Pharmaceutical Corporation Information
6.11.2 Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Description and Business Overview
6.11.3 Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Teva Pharmaceutical Product Portfolio
6.11.5 Teva Pharmaceutical Recent Developments/Updates
7 Angiotensin Receptor Blockers (ARBs) Manufacturing Cost Analysis
7.1 Angiotensin Receptor Blockers (ARBs) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Angiotensin Receptor Blockers (ARBs)
7.4 Angiotensin Receptor Blockers (ARBs) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Angiotensin Receptor Blockers (ARBs) Distributors List
8.3 Angiotensin Receptor Blockers (ARBs) Customers
9 Angiotensin Receptor Blockers (ARBs) Market Dynamics
9.1 Angiotensin Receptor Blockers (ARBs) Industry Trends
9.2 Angiotensin Receptor Blockers (ARBs) Growth Drivers
9.3 Angiotensin Receptor Blockers (ARBs) Market Challenges
9.4 Angiotensin Receptor Blockers (ARBs) Market Restraints
10 Global Market Forecast
10.1 Angiotensin Receptor Blockers (ARBs) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Angiotensin Receptor Blockers (ARBs) by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Angiotensin Receptor Blockers (ARBs) by Type (2022-2027)
10.2 Angiotensin Receptor Blockers (ARBs) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Angiotensin Receptor Blockers (ARBs) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Angiotensin Receptor Blockers (ARBs) by Application (2022-2027)
10.3 Angiotensin Receptor Blockers (ARBs) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Angiotensin Receptor Blockers (ARBs) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Angiotensin Receptor Blockers (ARBs) by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Angiotensin Receptor Blockers (ARBs) Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Angiotensin Receptor Blockers (ARBs) Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Angiotensin Receptor Blockers (ARBs) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Angiotensin Receptor Blockers (ARBs) Covered in This Study
Table 5. Global Angiotensin Receptor Blockers (ARBs) Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Angiotensin Receptor Blockers (ARBs) Sales Share by Manufacturers (2016-2021)
Table 7. Global Angiotensin Receptor Blockers (ARBs) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Angiotensin Receptor Blockers (ARBs) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Angiotensin Receptor Blockers (ARBs) Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Angiotensin Receptor Blockers (ARBs) Manufacturing Sites and Area Served
Table 11. Manufacturers Angiotensin Receptor Blockers (ARBs) Product Type
Table 12. Global Angiotensin Receptor Blockers (ARBs) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Angiotensin Receptor Blockers (ARBs) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angiotensin Receptor Blockers (ARBs) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Angiotensin Receptor Blockers (ARBs) Sales by Region (2016-2021) & (K MT)
Table 16. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Region (2016-2021)
Table 17. Global Angiotensin Receptor Blockers (ARBs) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Angiotensin Receptor Blockers (ARBs) Sales by Country (2016-2021) & (K MT)
Table 19. North America Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country (2016-2021)
Table 20. North America Angiotensin Receptor Blockers (ARBs) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country (2016-2021)
Table 22. Europe Angiotensin Receptor Blockers (ARBs) Sales by Country (2016-2021) & (K MT)
Table 23. Europe Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country (2016-2021)
Table 24. Europe Angiotensin Receptor Blockers (ARBs) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Angiotensin Receptor Blockers (ARBs) Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Angiotensin Receptor Blockers (ARBs) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Angiotensin Receptor Blockers (ARBs) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Angiotensin Receptor Blockers (ARBs) Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country (2016-2021)
Table 32. Latin America Angiotensin Receptor Blockers (ARBs) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Angiotensin Receptor Blockers (ARBs) Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Angiotensin Receptor Blockers (ARBs) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Angiotensin Receptor Blockers (ARBs) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Country (2016-2021)
Table 38. Global Angiotensin Receptor Blockers (ARBs) Sales (K MT) by Type (2016-2021)
Table 39. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Type (2016-2021)
Table 40. Global Angiotensin Receptor Blockers (ARBs) Revenue (Million US$) by Type (2016-2021)
Table 41. Global Angiotensin Receptor Blockers (ARBs) Revenue Share by Type (2016-2021)
Table 42. Global Angiotensin Receptor Blockers (ARBs) Price (USD/Unit) by Type (2016-2021)
Table 43. Global Angiotensin Receptor Blockers (ARBs) Sales (K MT) by Application (2016-2021)
Table 44. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Application (2016-2021)
Table 45. Global Angiotensin Receptor Blockers (ARBs) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Angiotensin Receptor Blockers (ARBs) Revenue Share by Application (2016-2021)
Table 47. Global Angiotensin Receptor Blockers (ARBs) Price (USD/Unit) by Application (2016-2021)
Table 48. Pfizer Corporation Information
Table 49. Pfizer Description and Business Overview
Table 50. Pfizer Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Pfizer Angiotensin Receptor Blockers (ARBs) Product
Table 52. Pfizer Recent Developments/Updates
Table 53. Novartis Corporation Information
Table 54. Novartis Description and Business Overview
Table 55. Novartis Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Novartis Angiotensin Receptor Blockers (ARBs) Product
Table 57. Novartis Recent Developments/Updates
Table 58. Merck Corporation Information
Table 59. Merck Description and Business Overview
Table 60. Merck Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Merck Angiotensin Receptor Blockers (ARBs) Product
Table 62. Merck Recent Developments/Updates
Table 63. Astra Zeneca Corporation Information
Table 64. Astra Zeneca Description and Business Overview
Table 65. Astra Zeneca Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Astra Zeneca Angiotensin Receptor Blockers (ARBs) Product
Table 67. Astra Zeneca Recent Developments/Updates
Table 68. Jhonson and Johnson Corporation Information
Table 69. Jhonson and Johnson Description and Business Overview
Table 70. Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Product
Table 72. Jhonson and Johnson Recent Developments/Updates
Table 73. Eli Lilly Corporation Information
Table 74. Eli Lilly Description and Business Overview
Table 75. Eli Lilly Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Eli Lilly Angiotensin Receptor Blockers (ARBs) Product
Table 77. Eli Lilly Recent Developments/Updates
Table 78. Sanofi Corporation Information
Table 79. Sanofi Description and Business Overview
Table 80. Sanofi Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Sanofi Angiotensin Receptor Blockers (ARBs) Product
Table 82. Sanofi Recent Developments/Updates
Table 83. Bristol-Myers Squibb Corporation Information
Table 84. Bristol-Myers Squibb Description and Business Overview
Table 85. Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Product
Table 87. Bristol-Myers Squibb Recent Developments/Updates
Table 88. Bayer Corporation Information
Table 89. Bayer Description and Business Overview
Table 90. Bayer Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Bayer Angiotensin Receptor Blockers (ARBs) Product
Table 92. Bayer Recent Developments/Updates
Table 93. GSK Corporation Information
Table 94. GSK Description and Business Overview
Table 95. GSK Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. GSK Angiotensin Receptor Blockers (ARBs) Product
Table 97. GSK Recent Developments/Updates
Table 98. Teva Pharmaceutical Corporation Information
Table 99. Teva Pharmaceutical Description and Business Overview
Table 100. Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Sales (K MT), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Product
Table 102. Teva Pharmaceutical Recent Developments/Updates
Table 103. Production Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Angiotensin Receptor Blockers (ARBs) Distributors List
Table 106. Angiotensin Receptor Blockers (ARBs) Customers List
Table 107. Angiotensin Receptor Blockers (ARBs) Market Trends
Table 108. Angiotensin Receptor Blockers (ARBs) Growth Drivers
Table 109. Angiotensin Receptor Blockers (ARBs) Market Restraints
Table 110. Global Angiotensin Receptor Blockers (ARBs) Sales Forecast by Type (2022-2027) & (K MT)
Table 111. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share Forecast by Type (2022-2027)
Table 112. Global Angiotensin Receptor Blockers (ARBs) Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 113. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share Forecast by Type (2022-2027)
Table 114. Global Angiotensin Receptor Blockers (ARBs) Sales Forecast by Application (2022-2027) & (K MT)
Table 115. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share Forecast by Application (2022-2027)
Table 116. Global Angiotensin Receptor Blockers (ARBs) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 117. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share Forecast by Application (2022-2027)
Table 118. Global Angiotensin Receptor Blockers (ARBs) Sales Forecast by Region (2022-2027) & (K MT)
Table 119. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share Forecast by Region (2022-2027)
Table 120. Global Angiotensin Receptor Blockers (ARBs) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 121. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share Forecast by Region (2022-2027)
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Angiotensin Receptor Blockers (ARBs)
Figure 2. Global Angiotensin Receptor Blockers (ARBs) Market Share by Type in 2020 & 2027
Figure 3. Valsartan Product Picture
Figure 4. Telmisartan Product Picture
Figure 5. Losartan Product Picture
Figure 6. Irbesartan Product Picture
Figure 7. Azilsartan Product Picture
Figure 8. Olmesartan Product Picture
Figure 9. Global Angiotensin Receptor Blockers (ARBs) Market Share by Application in 2020 & 2027
Figure 10. Hypertension
Figure 11. Cardiovascular Diseases
Figure 12. Kidney Diseases
Figure 13. Other
Figure 14. Global Angiotensin Receptor Blockers (ARBs) Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Angiotensin Receptor Blockers (ARBs) Market Size 2016-2027 (US$ Million)
Figure 16. Global Angiotensin Receptor Blockers (ARBs) Sales 2016-2027 (K MT)
Figure 17. Global Angiotensin Receptor Blockers (ARBs) Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 18. Angiotensin Receptor Blockers (ARBs) Sales Share by Manufacturers in 2020
Figure 19. Global Angiotensin Receptor Blockers (ARBs) Revenue Share by Manufacturers in 2020
Figure 20. The Global 5 and 10 Largest Angiotensin Receptor Blockers (ARBs) Players: Market Share by Revenue in 2020
Figure 21. Angiotensin Receptor Blockers (ARBs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 22. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Region (2016-2021)
Figure 23. Global Angiotensin Receptor Blockers (ARBs) Sales Market Share by Region in 2020
Figure 24. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Region (2016-2021)
Figure 25. Global Angiotensin Receptor Blockers (ARBs) Revenue Market Share by Region in 2020
Figure 26. U.S. Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Canada Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Germany Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. France Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. U.K. Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Italy Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Russia Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Japan Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. South Korea Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. India Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Australia Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Taiwan Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Indonesia Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Thailand Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Malaysia Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Philippines Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Vietnam Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Mexico Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Brazil Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Argentina Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Turkey Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Saudi Arabia Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. U.A.E Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Sales Market Share of Angiotensin Receptor Blockers (ARBs) by Type (2016-2021)
Figure 51. Sales Market Share of Angiotensin Receptor Blockers (ARBs) by Application (2016-2021)
Figure 52. Sales Market Share of Angiotensin Receptor Blockers (ARBs) by Application in 2020
Figure 53. Revenue Share of Angiotensin Receptor Blockers (ARBs) by Application (2016-2021)
Figure 54. Revenue Share of Angiotensin Receptor Blockers (ARBs) by Application in 2020
Figure 55. Manufacturing Cost Structure of Angiotensin Receptor Blockers (ARBs)
Figure 56. Manufacturing Process Analysis of Angiotensin Receptor Blockers (ARBs)
Figure 57. Angiotensin Receptor Blockers (ARBs) Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs